Conditions: Visual Impairment Macular Edema Central Retinal Vein Occlusion
Keywords: Visual impairment macular edema Central retinal vein occlusion Dexamethasone implant Ranibizumab
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 243
Healthy volunteers: no

Brief summary:
This clinical trial is designed to compare ranibizumab in comparison with Dexamethasone implant® after 6 months of treatment. In the study arm Lucentis will be given monthly in a pro re nata scheme whereas the comparator Dexamethasone implant is given once at Month 0 with sham injections PRN afterwards.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Ranibizumab intervention 2: Dexamethasone implant and sham injections
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: